South Wales, Nov. 20 -- United Kingdom Intellectual Property Office (UKIPO) has registered trademark "Plenty Biosimilars" on Sept. 26. The details about the trademark application no. UK00004451481 published in the journal no. 2026/047 (Nov. 20).

Plenty Biologics Limited filed the trademark application for the below mentioned good(s)/service(s).

Class 5 : Injectable pharmaceuticals; Pharmaceuticals; Pharmaceutical drugs; Biopharmaceuticals for the treatment of cancer; Pharmaceutical preparations and substances for use in oncology; Pharmaceutical preparations for use in oncology; Pharmaceutical products for the treatment of bone diseases; Dermatological pharmaceutical substances; Dermatological pharmaceutical products; Antibacterial pharmaceuticals; Pharmaceutical products for the treatment of viral diseases; Pharmaceutical preparations for the treatment of autoimmune diseases; Pharmaceutical products for the treatment of cancer; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations for the treatment of autoimmune disorders; Pharmaceutical preparations for the prevention of autoimmune diseases; Immunomodulators; Pharmaceutical preparations for treating rheumatological diseases; Pharmaceutical agents for epidermis; Pharmaceutical preparations and substances for the treatment of cancer; Pharmaceutical preparations for use in chemotherapy; Antitumor drugs; Pharmaceutical preparations for the treatment of tumours; Antineoplastic drugs; Pharmaceutical preparations and substances with anti-inflammatory properties; Anti-cancer drugs; Pharmaceutical preparations for the treatment of digestive diseases; Pharmaceutical preparations for treating arthritis; Pharmaceutical compositions; Medicines for the treatment of gastrointestinal diseases; Pharmaceutical preparations for the treatment of inflammatory disorders; Pharmaceutical preparations for the treatment of musculo-skeletal disorders; Pharmaceutical preparations for the treatment of Musculo-skeletal disorders; Pharmaceutical preparations and substances; Pharmaceutical preparations for the treatment of cancer; Regulatory proteins for medical use.

Class 42 : Pharmaceutical products development; Development of pharmaceutical preparations and medicines; Testing of pharmaceuticals; Pharmaceutical drug development services; Research and development of vaccines and medicines; Research of pharmaceuticals; Research and development in the pharmaceutical and biotechnology fields; Biotechnology testing; Laboratory services relating to the production of monoclonal antibodies; Conducting clinical trials for pharmaceutical products.

The original document can be viewed at: http://www.ipo.gov.uk/cgi-bin/redirect.cgi?type=tmj&link=6¶m1=UK00004451481

Disclaimer: Curated by HT Syndication.